Cingulate Stock Performance

CING Stock  USD 4.55  0.19  4.01%   
On a scale of 0 to 100, Cingulate holds a performance score of 5. The firm shows a Beta (market volatility) of -0.94, which signifies possible diversification benefits within a given portfolio. As the market becomes more bullish, returns on owning Cingulate are expected to decrease slowly. On the other hand, during market turmoil, Cingulate is expected to outperform it slightly. Please check Cingulate's sortino ratio, skewness, period momentum indicator, as well as the relationship between the potential upside and rate of daily change , to make a quick decision on whether Cingulate's price patterns will revert.

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Cingulate are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak basic indicators, Cingulate reported solid returns over the last few months and may actually be approaching a breakup point. ...more

Actual Historical Performance (%)

One Day Return
(4.01)
Five Day Return
(10.78)
Year To Date Return
(10.78)
Ten Year Return
(99.57)
All Time Return
(99.57)
Last Split Factor
1:12
Last Split Date
2024-08-09
1
Cingulate Reports Third Quarter 2024 Financial ResultsReflecting 19.5 Million Increase in Working Capital to Advance ADHD Drug to Market
11/07/2024
2
Cingulate Raised to Buy at Maxim Group
11/21/2024
3
Acquisition by Lawrence Bryan Jay of 5000 shares of Cingulate at 1.18 subject to Rule 16b-3
11/25/2024
4
Acquisition by Van Horn Louis G of 50000 shares of Cingulate at 1.79 subject to Rule 16b-3
12/23/2024
5
Acquisition by Brams Matthew of 1000 shares of Cingulate at 4.93 subject to Rule 16b-3
12/31/2024
6
Acquisition by Brams Matthew of 2748 shares of Cingulate at 4.76 subject to Rule 16b-3
01/17/2025
7
Acquisition by Silva Raul R. of 2748 shares of Cingulate at 4.76 subject to Rule 16b-3
01/22/2025
8
Cingulate Inc. adjusts executive compensation - Investing.com
01/24/2025
Begin Period Cash Flow5.4 M
  

Cingulate Relative Risk vs. Return Landscape

If you would invest  383.00  in Cingulate on November 2, 2024 and sell it today you would earn a total of  72.00  from holding Cingulate or generate 18.8% return on investment over 90 days. Cingulate is currently generating 0.45% in daily expected returns and assumes 5.9116% risk (volatility on return distribution) over the 90 days horizon. In different words, 52% of stocks are less volatile than Cingulate, and 92% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days Cingulate is expected to generate 6.94 times more return on investment than the market. However, the company is 6.94 times more volatile than its market benchmark. It trades about 0.08 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.14 per unit of risk.

Cingulate Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Cingulate's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Cingulate, and traders can use it to determine the average amount a Cingulate's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.0761

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsCING
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 5.91
  actual daily
52
52% of assets are less volatile

Expected Return

 0.45
  actual daily
8
92% of assets have higher returns

Risk-Adjusted Return

 0.08
  actual daily
5
95% of assets perform better
Based on monthly moving average Cingulate is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cingulate by adding it to a well-diversified portfolio.

Cingulate Fundamentals Growth

Cingulate Stock prices reflect investors' perceptions of the future prospects and financial health of Cingulate, and Cingulate fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Cingulate Stock performance.

About Cingulate Performance

By analyzing Cingulate's fundamental ratios, stakeholders can gain valuable insights into Cingulate's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Cingulate has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Cingulate has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Last ReportedProjected for Next Year
Days Of Inventory On Hand(10.53)(10.00)
Return On Tangible Assets(7.75)(7.36)
Return On Capital Employed 3.04  3.19 
Return On Assets(7.75)(7.36)
Return On Equity 3.08  3.24 

Things to note about Cingulate performance evaluation

Checking the ongoing alerts about Cingulate for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Cingulate help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Cingulate had very high historical volatility over the last 90 days
Cingulate has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (23.53 K) with loss before overhead, payroll, taxes, and interest of (15.49 M).
Cingulate currently holds about 8.2 M in cash with (15.04 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.73.
Cingulate has a poor financial position based on the latest SEC disclosures
Latest headline from news.google.com: Cingulate Inc. adjusts executive compensation - Investing.com
Evaluating Cingulate's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Cingulate's stock performance include:
  • Analyzing Cingulate's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Cingulate's stock is overvalued or undervalued compared to its peers.
  • Examining Cingulate's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Cingulate's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Cingulate's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Cingulate's stock. These opinions can provide insight into Cingulate's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Cingulate's stock performance is not an exact science, and many factors can impact Cingulate's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Cingulate Stock analysis

When running Cingulate's price analysis, check to measure Cingulate's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cingulate is operating at the current time. Most of Cingulate's value examination focuses on studying past and present price action to predict the probability of Cingulate's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cingulate's price. Additionally, you may evaluate how the addition of Cingulate to your portfolios can decrease your overall portfolio volatility.
Bonds Directory
Find actively traded corporate debentures issued by US companies
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Fundamental Analysis
View fundamental data based on most recent published financial statements
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges